Mecure Industries PLC (NGX:MECURE)

Market Cap	269.20B +498.2%
Revenue (ttm)	77.69B +68.8%
Net Income	6.46B +177.5%
EPS	1.62 +177.5%
Shares Out	4.00B
PE Ratio	41.66
Forward PE	n/a
Dividend	0.32 (0.47%)
Ex-Dividend Date	Apr 24, 2026

Volume	1,650,970
Average Volume	268,831
Open	74.10
Previous Close	67.60
Day's Range	67.30 - 74.10
52-Week Range	11.10 - 104.00
Beta	1.43
RSI	56.46
Earnings Date	Apr 28, 2026

About Mecure Industries

Mecure Industries PLC manufactures and sells pharmaceuticals in Nigeria. The company engages in distributing multivitamins products. It also offers antibiotics, antimalarials, antihypertensives, antidiabetics, analgesics and nsaids, proton pump inhibitors, and H2 receptor antagonists. In addition, the company provides blood tonics; cough, cold, and catarrh preparations; antihistamines; anthelmintic; antacids; steroids; antispasmodics; and antidiarrheals. Further, it is involved in the contract manufacturing services. It sells its products throu...

• Industry: Pharmaceutical Preparations
• Founded: 2005
• Employees: 195
• Stock Exchange: Nigerian Stock Exchange
• Ticker Symbol: MECURE

Financial Performance

In 2025, Mecure Industries's revenue was 77.69 billion, an increase of 68.80% compared to the previous year's 46.03 billion. Earnings were 6.46 billion, an increase of 177.52%.